
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 509971
[patent_doc_number] => 07199131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Sulfonamide and sulfamide substituted imidazoquinolines'
[patent_app_type] => utility
[patent_app_number] => 11/101369
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24155
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/199/07199131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11101369
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/101369 | Sulfonamide and sulfamide substituted imidazoquinolines | Apr 6, 2005 | Issued |
Array
(
[id] => 5859998
[patent_doc_number] => 20060229344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Method of treating amyotrophic lateral sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/101791
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3507
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11101791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/101791 | Method of treating amyotrophic lateral sclerosis | Apr 6, 2005 | Abandoned |
Array
(
[id] => 295781
[patent_doc_number] => 07541048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Coating compositions for bioactive agents'
[patent_app_type] => utility
[patent_app_number] => 11/099910
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12955
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541048.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099910 | Coating compositions for bioactive agents | Apr 5, 2005 | Issued |
Array
(
[id] => 7018820
[patent_doc_number] => 20050220839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Coating compositions for bioactive agents'
[patent_app_type] => utility
[patent_app_number] => 11/099796
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12994
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099796 | Coating compositions for bioactive agents | Apr 5, 2005 | Issued |
Array
(
[id] => 7005973
[patent_doc_number] => 20050171286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Copolymer-1 improvements in compositions of copolymers'
[patent_app_type] => utility
[patent_app_number] => 11/098432
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2285
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171286.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098432 | Copolymer-1 improvements in compositions of copolymers | Apr 4, 2005 | Issued |
Array
(
[id] => 5753532
[patent_doc_number] => 20060222681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Controlled degradation materials for therapeutic agent delivery'
[patent_app_type] => utility
[patent_app_number] => 11/098729
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7100
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222681.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098729 | Controlled degradation materials for therapeutic agent delivery | Apr 3, 2005 | Issued |
Array
(
[id] => 326652
[patent_doc_number] => 07514423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases'
[patent_app_type] => utility
[patent_app_number] => 11/096790
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7796
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514423.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096790 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases | Mar 31, 2005 | Issued |
Array
(
[id] => 5753462
[patent_doc_number] => 20060222611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Compositions and methods for delivery of caffeine'
[patent_app_type] => utility
[patent_app_number] => 11/094016
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3661
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222611.pdf
[firstpage_image] =>[orig_patent_app_number] => 11094016
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/094016 | Compositions and methods for delivery of caffeine | Mar 30, 2005 | Issued |
Array
(
[id] => 7070224
[patent_doc_number] => 20050245609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 11/095031
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7019
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245609.pdf
[firstpage_image] =>[orig_patent_app_number] => 11095031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/095031 | Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions | Mar 30, 2005 | Abandoned |
Array
(
[id] => 6606328
[patent_doc_number] => 20100063157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'CHEMICAL PROCESS AND NEW CRYSTALLINE FORM'
[patent_app_type] => utility
[patent_app_number] => 10/599145
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11062
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599145 | Chemical process and new crystalline form | Mar 29, 2005 | Issued |
Array
(
[id] => 7046255
[patent_doc_number] => 20050250850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Amino acid composition promoting collagen synthesis'
[patent_app_type] => utility
[patent_app_number] => 11/092890
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1890
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250850.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092890 | Amino acid composition promoting collagen synthesis | Mar 29, 2005 | Abandoned |
Array
(
[id] => 142080
[patent_doc_number] => 07691831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Pharmaceutical combination and method for treatment of reactive arthritis or bursitis'
[patent_app_type] => utility
[patent_app_number] => 11/096260
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3207
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096260 | Pharmaceutical combination and method for treatment of reactive arthritis or bursitis | Mar 28, 2005 | Issued |
Array
(
[id] => 281498
[patent_doc_number] => 07553497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Gelatin hard capsule enhancing the film strength'
[patent_app_type] => utility
[patent_app_number] => 11/088779
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2660
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553497.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088779 | Gelatin hard capsule enhancing the film strength | Mar 24, 2005 | Issued |
Array
(
[id] => 7069070
[patent_doc_number] => 20050244453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Composition and method for preparing biocompatible surfaces'
[patent_app_type] => utility
[patent_app_number] => 11/090655
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28771
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090655
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090655 | Composition and method for preparing biocompatible surfaces | Mar 24, 2005 | Issued |
Array
(
[id] => 6966073
[patent_doc_number] => 20050232970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Process and systems for biocompatible surfaces'
[patent_app_type] => utility
[patent_app_number] => 11/090517
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17728
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232970.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090517 | Process and systems for biocompatible surfaces | Mar 24, 2005 | Issued |
Array
(
[id] => 7595518
[patent_doc_number] => 07625942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Method of treating Down syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/593179
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/625/07625942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593179
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593179 | Method of treating Down syndrome | Mar 17, 2005 | Issued |
Array
(
[id] => 5784166
[patent_doc_number] => 20060204441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cell scaffold matrices with incorporated therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/084350
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23706
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084350
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084350 | Cell scaffold matrices with incorporated therapeutic agents | Mar 17, 2005 | Issued |
Array
(
[id] => 478834
[patent_doc_number] => 07223748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets'
[patent_app_type] => utility
[patent_app_number] => 11/073625
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9159
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223748.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073625 | Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets | Mar 7, 2005 | Issued |
Array
(
[id] => 326301
[patent_doc_number] => 07514071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Single-use cosmetic article'
[patent_app_type] => utility
[patent_app_number] => 11/074056
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6967
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074056 | Single-use cosmetic article | Mar 7, 2005 | Issued |
Array
(
[id] => 7046225
[patent_doc_number] => 20050250820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Therapeutic modulation of PPARgamma activity'
[patent_app_type] => utility
[patent_app_number] => 11/075090
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72353
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075090
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075090 | Therapeutic modulation of PPARgamma activity | Mar 6, 2005 | Abandoned |